Many cancer patients who received genomic testing of their cancers in a clinical trial did not fully understand the purpose of the testing.
by Emma Yasinski
A coalition of wives of African leaders, originally dedicated to addressing HIV/AIDS, is now also taking on the growing problem of cancer.
by Bradley D. Miller, PhD
FORWARD LOOK
Outcomes are often evaluated using progression-free survival.
by Jasenka Piljac Zegarac
Study supports use of single-session, higher-dose radiation.
by Jane Langille
CAR-T cell therapy has successfully treated some patients with leukemia and lymphoma. Researchers are looking to expand the range of cancers that will respond to the therapy.
by Kendall K. Morgan
Researchers look for easier ways to screen for colorectal cancer in Nigeria.
by Bradley Jones
Q&A
Biochemist Samuel H. Sternberg describes the limitations, realities and potential of gene-editing technology.
by Marci A. Landsmann
People with HIV who develop certain cancers are more likely to die from them than patients without HIV—even if they receive similar treatment.
by Jon Kelvey
Immune checkpoint inhibitors can be effective treatments for elderly people with some types of advanced cancer, but more information is needed on their risks and benefits in this group.
Uterine cancer incidence is increasing in the U.S., particularly in Hispanic, Asian and black women, but obesity may play a smaller role in this change than was previously assumed.
by Ashley P. Taylor
People with cancer are at increased risk of serious complications if they get the flu. Flu shots are safe for this group, and a recent study bolsters evidence of their effectiveness.
by Carly Weeks
The fall 2019 Cancer Today tells the stories of advocates who are using the internet to amplify their voices, patients who are navigating the world of complementary medicine and researchers who are devising new immunotherapies.
by Kevin McLaughlin
Despite progress in developing new treatment modalities for patients with breast cancer, there is still substantial work to be done in the field.
The immune checkpoint inhibitor Keytruda (pembrolizumab) has been approved for use by some patients with endometrial cancer.
October is Liver Cancer Awareness Month. Here’s a look at the latest statistics and trends.
Follow My Lead
donate to the AACR